354 related articles for article (PubMed ID: 28338087)
1. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.
Ramaswamy G; Kim H; Zhang D; Lounev V; Wu JY; Choi Y; Kaplan FS; Pignolo RJ; Shore EM
Sci Rep; 2017 Mar; 7():45140. PubMed ID: 28338087
[TBL] [Abstract][Full Text] [Related]
2. Ablation of Gsα signaling in osteoclast progenitor cells adversely affects skeletal bone maintenance.
Ramaswamy G; Fong J; Brewer N; Kim H; Zhang D; Choi Y; Kaplan FS; Shore EM
Bone; 2018 Apr; 109():86-90. PubMed ID: 29183785
[TBL] [Abstract][Full Text] [Related]
3. Induced
Khan SK; Yadav PS; Elliott G; Hu DZ; Xu R; Yang Y
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E418-E427. PubMed ID: 29158412
[TBL] [Abstract][Full Text] [Related]
4. Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways.
Weivoda MM; Ruan M; Hachfeld CM; Pederson L; Howe A; Davey RA; Zajac JD; Kobayashi Y; Williams BO; Westendorf JJ; Khosla S; Oursler MJ
J Bone Miner Res; 2016 Jan; 31(1):65-75. PubMed ID: 26189772
[TBL] [Abstract][Full Text] [Related]
5. Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation.
Zhang S; Kaplan FS; Shore EM
Horm Metab Res; 2012 Sep; 44(10):724-31. PubMed ID: 22903279
[TBL] [Abstract][Full Text] [Related]
6. GNAS mutations and heterotopic ossification.
Bastepe M
Bone; 2018 Apr; 109():80-85. PubMed ID: 28889026
[TBL] [Abstract][Full Text] [Related]
7. Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.
Azab E; Chandler KB; Uda Y; Sun N; Hussein A; Shuwaikan R; Lu V; Costello CE; McComb ME; Divieti Pajevic P
FASEB J; 2020 Aug; 34(8):10191-10211. PubMed ID: 32557809
[TBL] [Abstract][Full Text] [Related]
8. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
[TBL] [Abstract][Full Text] [Related]
9. The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways.
Wilson CH; McIntyre RE; Arends MJ; Adams DJ
Oncogene; 2010 Aug; 29(32):4567-75. PubMed ID: 20531296
[TBL] [Abstract][Full Text] [Related]
10. Constitutive stimulatory G protein activity in limb mesenchyme impairs bone growth.
Karaca A; Malladi VR; Zhu Y; Tafaj O; Paltrinieri E; Wu JY; He Q; Bastepe M
Bone; 2018 May; 110():230-237. PubMed ID: 29471062
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Gα
Zhang L; Sugamori KS; Claridge C; Dela Cruz A; Grynpas MD; Mitchell J
J Bone Miner Res; 2017 Nov; 32(11):2171-2181. PubMed ID: 28727179
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo.
Bastepe M; Weinstein LS; Ogata N; Kawaguchi H; Jüppner H; Kronenberg HM; Chung UI
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14794-9. PubMed ID: 15459318
[TBL] [Abstract][Full Text] [Related]
13. Constitutive Activation of β-Catenin in Differentiated Osteoclasts Induces Bone Loss in Mice.
Sui X; Deng S; Liu M; Fan L; Wang Y; Xu H; Sun Y; Kishen A; Zhang Q
Cell Physiol Biochem; 2018; 48(5):2091-2102. PubMed ID: 30107384
[TBL] [Abstract][Full Text] [Related]
14. Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.
Mariot V; Wu JY; Aydin C; Mantovani G; Mahon MJ; Linglart A; Bastepe M
Bone; 2011 Feb; 48(2):312-20. PubMed ID: 20887824
[TBL] [Abstract][Full Text] [Related]
15. Adenylate cyclase and calmodulin-dependent kinase have opposite effects on osteoclastogenesis by regulating the PKA-NFATc1 pathway.
Yoon SH; Ryu Jy; Lee Y; Lee ZH; Kim HH
J Bone Miner Res; 2011 Jun; 26(6):1217-29. PubMed ID: 21611964
[TBL] [Abstract][Full Text] [Related]
16. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
[TBL] [Abstract][Full Text] [Related]
17. Dopamine suppresses osteoclast differentiation via cAMP/PKA/CREB pathway.
Wang L; Han L; Xue P; Hu X; Wong SW; Deng M; Tseng HC; Huang BW; Ko CC
Cell Signal; 2021 Feb; 78():109847. PubMed ID: 33242564
[TBL] [Abstract][Full Text] [Related]
18. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XLalphas.
Linglart A; Mahon MJ; Kerachian MA; Berlach DM; Hendy GN; Jüppner H; Bastepe M
Endocrinology; 2006 May; 147(5):2253-62. PubMed ID: 16484323
[TBL] [Abstract][Full Text] [Related]
19. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
20. Sfrp4 repression of the Ror2/Jnk cascade in osteoclasts protects cortical bone from excessive endosteal resorption.
Chen K; Ng PY; Chen R; Hu D; Berry S; Baron R; Gori F
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14138-14143. PubMed ID: 31239337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
